EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment

Xinyu Fu, Weige Wu, Yuru Wu, Xiaofu Liu, Wanting Liang, Rongchuan Wu, Yun Li

Frontiers in Psychiatry · 06.06.2025 · 16

DOI: 10.3389/fpsyt.2025.1597559 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 06.06.2025. Verfasst von Xinyu Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that is known for its high degree of heterogeneity. It often coexists with other psychiatric diseases, especially anxiety and depression. This article reviews recent studies to explore the etiology of comorbid anxiety and depressive disorders in adults with ADHD, analyzing the factors contributing to this elevated comorbidity rate from several perspectives. Additionally, we explore potential directions for future research in this field. Recent findings ADHD exhibits a high comorbidity rate with anxiety and depressive disorders, due to overlapping and interacting symptoms. Individuals with two or more comorbid conditions often experience increased disease burden, prolonged illness duration, and diminished treatment efficacy. The underlying causes of comorbid anxiety and depression in ADHD patients are highly complex and can be understood from multiple dimensions, including genetics, neurobiology, neurocognition, and neuroimaging. This complexity poses significant challenges for clinical diagnosis and treatment. Currently, the management of ADHD patients with concurrent depression or anxiety may involve pharmaceutical interventions combined with non-pharmacological strategies, including psychotherapy (e.g., cognitive-behavioral therapy, CBT) and digital therapeutics. For patients with comorbid illnesses, these intergrated approaches have demonstrated significant improvements in symptom relief and quality of life enhancement. Summary ADHD is a highly heterogeneous disorder with a significant comorbidity rate. Recent research has elucidated the pathogenetic mechanisms of ADHD comorbid with depression and anxiety disorders from multiple perspectives. To improve patient functioning, enhance their quality of life, and guide more effective treatments, Further studies are needed to investigate the underlying causes of these comorbid conditions.

Schlagwörter

Stichwörter der Autor:innen

adult ADHDanxiety and depressive disorderscomorbidityetiologytreatment

Autor:innen und Institutionen

  • The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China.
  • Xiamen Xianyue Hospital, Xianyue Hospital Affiliated with Xiamen Medical College, Fujian Psychiatric Center, Fujian Clinical Research Center for Mental Disorders, Xiamen, Fujian, China.

Zitieren

APA

Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y. (2025). Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1597559

Vancouver

Fu X, Wu W, Wu Y, Liu X, Liang W, Wu R, et al. Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Frontiers in Psychiatry. 2025;16. doi:10.3389/fpsyt.2025.1597559

BibTeX
@article{Fu2025,
  author = {Fu, Xinyu and Wu, Weige and Wu, Yuru and Liu, Xiaofu and Liang, Wanting and Wu, Rongchuan and Li, Yun},
  title = {Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment},
  journal = {Frontiers in Psychiatry},
  year = {2025},
  volume = {16},
  doi = {10.3389/fpsyt.2025.1597559}
}
Kostenlos starten →